Provided by Tiger Trade Technology Pte. Ltd.

Omeros

19.27
+0.64003.44%
Post-market: 19.19-0.0800-0.42%19:58 EDT
Volume:2.58M
Turnover:49.49M
Market Cap:1.39B
PE:12.26
High:19.58
Open:18.64
Low:18.41
Close:18.63
52wk High:19.58
52wk Low:3.94
Shares:72.38M
Float Shares:67.73M
Volume Ratio:1.06
T/O Rate:3.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.57
EPS(LYR):-0.0527
ROE:-576.33%
ROA:-18.68%
PB:-27.16
PE(LYR):-365.33

Loading ...

H.C. Wainwright Keeps Their Buy Rating on Omeros (OMER)

TIPRANKS
·
May 14

Omeros Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Stock Track | Omeros Soars 5.14% After-Hours on Strong Q1 Profit Turnaround and YARTEMLEA Launch Progress

Stock Track
·
May 14

Omeros reports Q1 adjusted EPS (24c), consensus (28c)

TIPRANKS
·
May 14

Omeros Q1 Adjusted Loss Narrows

MT Newswires Live
·
May 14

Omeros Q1 net income turns positive after YARTEMLEA launch

Reuters
·
May 14

Omeros Q1 FY26 swings to net profit of USD 56.1 million; net sales USD 9.9 million

Reuters
·
May 14

Omeros Q1 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $9.893M Miss $10.125M Estimate

Benzinga Earnings
·
May 14

BRIEF-Omeros Corporation Q1 EPS USD 0.78

Reuters
·
May 14

Omeros Corporation Q1 Net Income USD 56.1 Million

THOMSON REUTERS
·
May 14

Omeros options imply 10.8% move in share price post-earnings

TIPRANKS
·
May 14

Press Release: Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Dow Jones
·
May 12

Omeros to report first-quarter results, hosts conference call after market close

Reuters
·
May 12

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 21

Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires

Reuters
·
Apr 20

Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Dow Jones
·
Apr 20

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA

TIPRANKS
·
Apr 16

CMS Assigns Permanent Reimbursement J-Code for Yartemlea® (Narsoplimab-Wuug)

THOMSON REUTERS
·
Apr 16

Omeros Corp - J-Code J1289 for Yartemlea Effective July 1, 2026

THOMSON REUTERS
·
Apr 16

Omeros Turns Corner With Novo Deal, YARTEMLEA Launch

TIPRANKS
·
Apr 04